Novo Holdings A/S - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 42 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,344,169
+16.0%
3,330,3770.0%1.87%
+11.0%
Q2 2023$21,847,273
+6.5%
3,330,377
-2.9%
1.69%
+24.8%
Q1 2023$20,513,654
+156.7%
3,430,3770.0%1.35%
+171.1%
Q4 2022$7,992,778
-30.4%
3,430,3770.0%0.50%
-8.9%
Q3 2022$11,492,000
+26.4%
3,430,3770.0%0.55%
+22.3%
Q2 2022$9,090,000
-9.9%
3,430,3770.0%0.45%
-15.8%
Q1 2022$10,085,000
-65.6%
3,430,3770.0%0.53%
-61.7%
Q4 2021$29,330,000
+14.8%
3,430,3770.0%1.39%
+5.1%
Q3 2021$25,556,000
-20.1%
3,430,3770.0%1.32%
-6.9%
Q2 2021$32,005,0003,430,3771.42%
Other shareholders

There were no reported owners of RENEO PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of RENEO PHARMACEUTICALS INC shareholders